Cargando…
Immuno‐Oncology in China
Immuno‐oncology has been heralded as a breakthrough cancer treatment, and Chinese researchers have emerged as important contributors to this area of research. The Immuno‐Oncology Special Issue highlights articles by researchers in China, focusing on immunotherapy for various cancer types from differ...
Autores principales: | Lu, Shun, Chabner, Bruce A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6394771/ https://www.ncbi.nlm.nih.gov/pubmed/30819825 http://dx.doi.org/10.1634/theoncologist.2019-IO-S1-edi |
Ejemplares similares
-
Supreme Court and the Practice of Oncology
por: Chabner, Bruce A, et al.
Publicado: (2022) -
Regarding “Oncology Drug Approvals: Evaluating Endpoints and Evidence in an Era of Breakthrough Therapies”
por: Chabner, Bruce A.
Publicado: (2017) -
Immuno-Oncology
por: Chaudhuri, Swapna
Publicado: (2017) -
COVID-19, Immuno-oncology and Cardiovascular Disease: Viewpoint from the Intersection
por: Siddiqi, Hasan K., et al.
Publicado: (2020) -
Academia–Pharma Intersect: Providing a Broader Perspective on Drug Development Synergies between Academia and Industry
por: Chabner, Bruce A.
Publicado: (2010)